MoneyWorks4Me

Lupin informs about press release

12 Apr 2024 Evaluate

Lupin has informed that it enclosed a Press Release as regards, the successful completion of GMP Inspection by the U.S. FDA, of the Company’s API manufacturing facility located at Dabhasa, India. The inspection was conducted from April 8 to April 12, 2024 and concluded with no observations. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..